Christopher R. Cline
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 27,473110,543 held (−20%) | $62.00 | $1.7M | -15.9% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 20,73589,808 held (−19%) | $62.61 | $1.3M | -16.7% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,90087,908 held (−2%) | $63.69 | $121K | -18.2% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 40087,508 held (−0%) | $65.31 | $26K | -20.2% |
| Sep 3SEC | TVTXTravere Therapeutics, Inc. | Sell | 642118,016 held (−1%) | $66.37 | $43K | -21.5% |
| May 6SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 2,181118,968 held (−2%) | $46.65 | $102K | +11.7% |
| May 6SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 310118,658 held (−0%) | $43.95 | $14K | +18.6% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 65125,161 held (−0%) | $28.85 | $2K | +80.7% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 9125,152 held (−0%) | $41.07 | $370 | +26.9% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 7,239117,913 held (−6%) | $41.93 | $304K | +24.3% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,014116,899 held (−1%) | $42.61 | $43K | +22.3% |
| Feb 5SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,635111,336 held (−1%) | $32.14 | $53K | +62.2% |
| Feb 5SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 110111,226 held (−0%) | $32.90 | $4K | +58.4% |
| Feb 3SEC | TVTXTravere Therapeutics, Inc. | Sell | 7,242112,971 held (−6%) | $32.12 | $233K | +62.3% |
| Dec 3SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 20,00092,083 held (−18%) | $35.01 | $700K | +48.9% |
- Sell
CFO Christopher R. Cline sold $1.7M of TVTX at $62.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Christopher R. Cline sold $1.3M of TVTX at $62.61 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Christopher R. Cline sold $121K of TVTX at $63.69 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Christopher R. Cline sold $26K of TVTX at $65.31 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Christopher R. Cline sold $102K of TVTX at $46.65 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Christopher R. Cline sold $14K of TVTX at $43.95 — pre-scheduled 10b5-1 plan sale.